These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26518894)

  • 1. TRAIL and targeting cancer cells: between promises and obstacles.
    Limami Y; Pinon A; Riaz A; Simon A
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):33-8. PubMed ID: 26518894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL receptor signaling and therapeutics.
    Abdulghani J; El-Deiry WS
    Expert Opin Ther Targets; 2010 Oct; 14(10):1091-108. PubMed ID: 20819019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-based therapeutic approaches for the treatment of pediatric malignancies.
    Gasparini C; Vecchi Brumatti L; Monasta L; Zauli G
    Curr Med Chem; 2013; 20(17):2254-71. PubMed ID: 23458616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAIL: a sword for killing tumors.
    Wang S
    Curr Med Chem; 2010; 17(29):3309-17. PubMed ID: 20712573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy.
    Singh D; Tewari M; Singh S; Narayan G
    Future Oncol; 2021 Feb; 17(5):581-596. PubMed ID: 33401962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TRAIL apoptotic pathway in cancer onset, progression and therapy.
    Johnstone RW; Frew AJ; Smyth MJ
    Nat Rev Cancer; 2008 Oct; 8(10):782-98. PubMed ID: 18813321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS).
    Mellier G; Pervaiz S
    Free Radic Res; 2012 Aug; 46(8):996-1003. PubMed ID: 22559302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.
    Cretney E; Takeda K; Smyth MJ
    Int J Biochem Cell Biol; 2007; 39(2):280-6. PubMed ID: 17097329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of TRAIL receptor agonists in cancer treatment.
    Fulda S
    Eur J Clin Pharmacol; 2015 May; 71(5):525-7. PubMed ID: 25704217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting death-receptors in radiation therapy.
    Niemöller O; Belka C
    Results Probl Cell Differ; 2009; 49():219-39. PubMed ID: 19582410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL): A Promising Therapeutic Strategy in Gliomas.
    Alexiou GA; Tsamis KI; Kyritsis AP
    Semin Pediatr Neurol; 2015 Mar; 22(1):35-9. PubMed ID: 25976259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL and cancer therapy.
    Kruyt FA
    Cancer Lett; 2008 May; 263(1):14-25. PubMed ID: 18329793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is TRAIL the holy grail of cancer therapy?
    Newsom-Davis T; Prieske S; Walczak H
    Apoptosis; 2009 Apr; 14(4):607-23. PubMed ID: 19194800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells.
    Oh S; Kwon D; Lee HJ; Kim J; Lee E
    Apoptosis; 2010 Dec; 15(12):1517-28. PubMed ID: 20623193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Apo2L/TRAIL receptors by soluble Apo2L/TRAIL.
    Holland PM
    Cancer Lett; 2013 May; 332(2):156-62. PubMed ID: 21220186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances for research on anti-tumor effects of TNF-related apoptosis-inducing ligand].
    Yao GH; Hou YY
    Wei Sheng Yan Jiu; 2006 Jan; 35(1):115-7. PubMed ID: 16598953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway.
    Wang S
    Oncogene; 2008 Oct; 27(48):6207-15. PubMed ID: 18931688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.